Ingevity reported third-quarter 2026 results, with net sales down 8% to $305.1 million, mainly because of the April 15, 2026 sale of the Road Markings product line. Net income from continuing operations rose to $51.1 million, or $1.46 per diluted share, from $40.8 million, or $1.10, a year earlier. The company narrowed its full-year adjusted EBITDA outlook to $385 million to $395 million while keeping the midpoint of the prior range, and said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
Net sales of $305.1 million fell 8%; excluding Road Markings, sales rose 2%.
Net income from continuing operations was $51.1 million, or $1.46 per diluted share, versus $1.10 a year earlier.
Adjusted EBITDA was $108.0 million, down $2.4 million; full-year adjusted EBITDA outlook narrowed to $385 million to $395 million.
Management said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Ingevity, Corp.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.17B
-2.7%
$-4.61
—
-14.3%
FY2024
$1.20B
-1.3%
$-11.85
—
-35.9%
FY2023
$1.22B
-27.1%
$-0.15
-102.7%
-0.4%
FY2022
$1.67B
+19.9%
$5.50
+86.4%
12.7%
FY2021
$1.39B
+14.4%
$2.95
-32.5%
8.5%
Frequently asked questions
When is Ingevity's next earnings date?
Ingevity has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Ingevity earn last quarter?
For the quarter ended Sep 2026, Ingevity reported diluted EPS of $1.41 (+19.5% year over year) on revenue of $305.10M (-8.4%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.